Urwashanza/europrocure-10-public-procurement huggingface dataset:
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Terri Hudson (WSCC)
Country: UK
Contract type: Works
Procedure: Competitive dialogue
CPV classification: 45000000: Construction work | 45111000 | 45112700 | 45210000: Building construction work | 45211100
Estimated value: 190000000 GBP
Award criteria: The most economic tender

Technical requirements: RE Novartis Pharmaceuticals site in Horsham. Originally offices, laboratories and workshops, now vacant and mostly demolished. 4 buildings retained inc 2 gate house buildings and a 1930s Art Deco style building and its extensions. Central structure is locally listed, assumed to be retained. The key driver is to build on the site’s long-established position as a major employment generator committed to ensuring the site makes a significant contribution to creating and supporting jobs and contributing to the West Sussex economy. Secured outline planning permission for the redevelopment of the site for up to 300 dwellings (C3) including the conversion of Buildings 3 and 36 and up to 25 000 m
The key objectives of the partnership will be to create and improve job opportunities, housing availability, local infrastructure and the local economy. The Council will procure and manage the initial site enabling works and infrastructure upgrades. Four buildings have been retained from the original site. These include two gate house buildings and a 1930s Art Deco style building and its extensions (Buildings 3 and 36) that were used for offices. The central structure is locally listed, and it is assumed it will be retained. In 2020 the Council secured outline planning permission for the redevelopment of the site for up to 300 dwellings (C3) including the conversion of Buildings 3 and 36 and up to 25 000 m
The estimated values in II.1.5) and II.2.6) represent the potential commercial value of the development. However, potential returns will depend on many commercial factors including (but not limited to) the performance of the developer and market conditions. Bidders should seek independent legal and commercial advice in relation to the potential value of the opportunity and the scheme as a whole.


Winner: Muse Developments Ltd
Award value: 190000000
Number of bids: 8
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Northern Ireland Housing Executive
Country: UK
Contract type: Works
Procedure: Open procedure
CPV classification: 45210000: Building construction work | 45211000: Construction work for multi-dwelling buildings | 45215210 | 45453100
Estimated value: 6072284.93 GBP
Award criteria: Lowest price

Technical requirements: The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven Lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven Lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven Lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.
The Housing Executive wishes to procure suitably qualified and competent contractors to carry out works in relation to bathroom, kitchen and domestic electrical rewire to Housing executive properties. It is proposed to have seven Lots awarded to a maximum of seven contractors. The lots will be awarded as detailed in the tender documents.


Winner: P.K. Murphy Construction Ltd
Award value: 6072284.93
Number of bids: 10
Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2021-03-12
Buyer: Centrul pentru Achiziții Publice Centralizate în Sănătate
Country: MD
Contract type: Supplies
CPV classification: 33000000 | 33100000
Estimated value: 26236604.36 MDL

Technical requirements: Realizarea Programului Naţional „Securitatea transfuzională şi autoasigurarea ţării cu produse sanguine” reactive și consumabile medicale conform necesităților pentru anul 2021 (repetat)
Realizarea Programului Naţional „Securitatea transfuzională şi autoasigurarea ţării cu produse sanguine” reactive și consumabile medicale conform necesităților pentru anul 2021 (repetat).
Lot nr. 1 – Teste pentru tehnologia de examinare de laborator a donatorilor de sânge/componente sanguine și sângelui/componentelor sanguine donat la prima etapă de triere
Centrul Național de Transfuzie a Sângelui, MD-2028, Republica Moldova, Chișinău, Str. Academiei nr. 11.
Teste pentru tehnologia de examinare de laborator a donatorilor de sânge/componente sanguine și sângelui/componentelor sanguine donat la prima etapă de triere în număr total de 260 300 teste, inclusiv:
1.1. prin tehnologia aplicată la dispozitivele aflate în dotarea instituției, cu toate componentele: număr de teste, accesorii/consumabile/reagenți/calibratori/soluții și alte produse obligatorii, inclusiv aferente activității dispozitivului medical de laborator aflat în dotarea instituției, necesare în procesul de examinare de laborator a sîngelui donat, corespunzător:
3. destinaţie: pentru examinarea sângelui de donator la marcheri infecţii hemotransmisibile – hepatita virală B.
1. test pentru screeningul sângelui donat și destinat pentru transfuzie sau ca materie primă pentru producerea preparatelor din plasmă umană, de generație care va asigura detectarea:
Componente de însoțire a produsului diagnostic: obligatoriu prezente toate componentele necesare, în cantități suficiente pentru aplicarea testului în reacția de testare, conform instrucţiunii de utilizare a produsului.
Forma de ambalare: setul livrat în ambalaj securizat, marcat şi etichetat de producător cu menţionarea datelor de identitate (denumire, număr lot/serie, termenii de valabilitate, condiţii de păstrare). Datele de identitate expuse pe cutie vor coincide în mod obligator cu cele de pe etichetele fiecărei componente a setului.
— Scrisoare de confirmare a fiecărei cerințe tehnice din criteriile de eligibilitate pentru produsul ofertat, emisă de producătorul de origine a produsului, semnată și parafată;
— Prezenţa instrucţiunii de utilizare a produsului de la producător, în limba de stat, parafată de operatorul economic;
— Confirmarea precum la livrare termenul de valabilitate a produsului va fi nu mai mic de 80 % din termenul total de valabilitate a acestuia;
4. destinaţie: pentru examinarea sîngelui de donator la marcheri infecţii hemotransmisibile – hepatita virală C.
1. test pentru screeningul sângelui donat și destinat pentru transfuzie sau ca materie primă pentru producerea preparatelor din plasmă umană, de generație care va asigura detectarea:


Award value: 26236604.36
Public procurement notice: Contract Notice
Published: 2021-03-12
Buyer: Centrul pentru Achiziții Publice Centralizate în Sănătate
Country: MD
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33000000 | 33100000
Estimated value: 26236604.36 MDL
Submission deadline: 2021-03-21
Award criteria: Lowest price

Technical requirements: Realizarea Programului Naţional „Securitatea transfuzională şi autoasigurarea ţării cu produse sanguine” reactive și consumabile medicale conform necesităților pentru anul 2021 (repetat)
Realizarea Programului Naţional „Securitatea transfuzională şi autoasigurarea ţării cu produse sanguine” reactive și consumabile medicale conform necesităților pentru anul 2021 (repetat).
Lot nr. 1 – Teste pentru tehnologia de examinare de laborator a donatorilor de sânge/componente sanguine și sângelui/componentelor sanguine donat la prima etapă de triere.
Centrul Național de Transfuzie a Sângelui, MD-2028, Republica Moldova, Chișinău, str. Academiei nr. 11
Teste pentru tehnologia de examinare de laborator a donatorilor de sânge/componente sanguine și sângelui/componentelor sanguine donat la prima etapă de triere în număr total de 260300 teste, inclusiv:
1) 1) prin tehnologia aplicată la dispozitivele aflate în dotarea instituției, cu toate componentele: număr de teste, accesorii/consumabile/reagenți/calibratori/soluții și alte produse obligatorii, inclusiv aferente activității dispozitivului medical de laborator aflat în dotarea instituției, necesare în procesul de examinare de laborator a sîngelui donat, corespunzător:
3) Destinaţie: pentru examinarea sîngelui de donator la marcheri infecţii hemotransmisibile – hepatita virală B.
1) test pentru screeningul sângelui donat și destinat pentru transfuzie sau ca materie primă pentru producerea preparatelor din plasmă umană, de generație care va asigura detectarea:
Componente de însoțire a produsului diagnostic: obligatoriu prezente toate componentele necesare, în cantități suficiente pentru aplicarea testului în reacția de testare, conform instrucţiunii de utilizare a produsului.
Forma de ambalare: setul livrat în ambalaj securizat, marcat şi etichetat de producător cu menţionarea datelor de identitate (denumire, număr lot/serie, termenii de valabilitate, condiţii de păstrare). Datele de identitate expuse pe cutie vor coincide în mod obligator cu cele de pe etichetele fiecărei componente a setului.
— Scrisoare de confirmare a fiecărei cerințe tehnice din criteriile de eligibilitate pentru produsul ofertat, emisă de producătorul de origine a produsului, semnată și parafată,
— Prezenţa instrucţiunii de utilizare a produsului de la producător, în limba de stat, parafată de operatorul economic,
— Confirmarea precum la livrare termenul de valabilitate a produsului va fi nu mai mic de 80 % din termenul total de valabilitate a acestuia.
4) Destinaţie: pentru examinarea sîngelui de donator la marcheri infecţii hemotransmisibile – hepatita virală C.
1) test pentru screeningul sângelui donat și destinat pentru transfuzie sau ca materie primă pentru producerea preparatelor din plasmă umană, de generație care va asigura detectarea:


Award value: 26236604.36
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 189600 GBP
Award criteria: The most economic tender

Technical requirements: The Department of Health and Social Care (DHSC) has awarded a contract for the supply, repackaging and relabelling of Favipiravir (Avigan) for Covid-19.
The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the supply of 300 packs of 100 tablets of Favipiravir 200 mg (Avigan). The contract period expires on 31 March 2021.
The coronavirus disease (Covid-19) gave rise to an extremely urgent need for the authority to purchase a quantity of Favipiravir because the authority needs to be in a position to treat the population as required such that did not give the authority sufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement.


Winner: IPS Pharma t/a Vertical Pharma Resources Ltd
Award value: 189600
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Qualifications Wales
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 48000000 | 48440000 | 48442000 | 48443000 | 48450000
Estimated value: 301287 GBP
Award criteria: The most economic tender

Technical requirements: The provision of Finance and HR cloud software (SAAS or other similar hosted arrangement) to include software licensing, implementation, training, support and other services.
Interface with the HR software(Lot 2) — No longer required. Changed to interface with a third party expenses system.
We require software licensing, implementation services, training (core users and train the trainer), ongoing support and services.
We may choose to defer introduction of the recruitment, flexi-time and performance management requirements or may not implement at all during the life of the contract.
We require software licensing, implementation services, training (core users and train the trainer), ongoing support and services.
The contract values are based on implementation, licensing, hosting and support for an initial period of 5 years.


Winner: Civica UK Ltd
Award value: 301287
Number of bids: 5
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products | 63120000
Estimated value: 8282390 GBP
Award criteria: Lowest price

Technical requirements: The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, as indicated in the order form which will then be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed exit plan, to buy back the stock.
The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, as indicated in the order form which will then be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the Supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed exit plan, to buy back the stock. The agreement is for twelve (12) months with the authority having the option (at its sole discretion) to extend the contract for up to two (2) periods of six (6) months.
Direct Award against NHS Supply Chain Framework — Renal Replacement Therapies Services, Technologies and Consumables — Lot 3.


Winner: Baxter Healthcare Ltd
Award value: 8282390
Number of bids: 3
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products | 63120000
Estimated value: 4116819 GBP
Award criteria: Lowest price

Technical requirements: The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, which will be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed Exit Plan, to buy back the stock. The agreement is for twelve (12) months with the option to extend the contract for a further period of up to twelve (12) months subject to the written agreement of both parties.
The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, which will be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed exit plan, to buy back the stock. The agreement is for twelve (12) months with the option to extend the contract for a further period of up to twelve (12) months subject to the written agreement of both parties.
Direct Award against NHS Supply Chain Framework — Renal Replacement Therapies Services, Technologies and Consumables — Lot 3.


Winner: Fresenius Medical Care (UK) Ltd
Award value: 4116819
Number of bids: 3
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 1527832.4 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure a number of additional supportive medicines including end of life, intensive care and antibiotics for treatments relating to Covid-19 — urgent delivery required for available stocks.
The Coronavirus disease (Covid-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The WHO Director General characterised Covid-19 as a pandemic on 11 March 2020, by this stage Europe was at the centre of the pandemic. During the initial response to the Covid-19 virus (the virus) and due to high global demand, there was concern around the availability of certain medicines used in intensive treatment units and for end of life care (the medicines) and there was a focus on ensuring the medicines would continue to be available to avoid the NHS running out and the impact of this on public health. Although wave 1 of the virus had subsided, the contracting authority was expecting and planning for an imminent second wave, and anticipated that the high global demand for the supplies of the medicines would be similar to wave 1. The contracting authority, having identified suppliers that were ready, willing and able to supply the medicines, needed to move quickly to secure the available supply. Failure to do this would have resulted in the medicines being sold by the suppliers to another country due to the high global demand. It was imperative to maintain security of supply for public health purposes. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was not feasible in order for the contracting authority to secure sufficient supply of the Medicines. The contracts are for the benefit of the Authority and NHS Bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
The contracts are for the benefit of the Authority and NHS Bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or nondepartmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.


Winner: Fresenius Kabi Ltd
Award value: 1527832.4
Number of bids: 5
Public procurement notice: Contract Award Notice
Published: 2021-03-12
Buyer: Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products | 63120000
Estimated value: 500703.4 GBP
Award criteria: Lowest price

Technical requirements: The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, which will be stored as a stockpile by the supplier. The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, which will be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed Exit Plan, to buy back the stock.
The Department of Health and Social Care (DHSC) has procured a range of Continuous Renal Replacement Therapies (CRRT) consumables and equipment, which will be stored as a stockpile by the supplier. It is intended for the products to be distributed for patients solely in the UK during a pandemic or other period of increased demand and/or potential shortage in the UK and for this purpose the stockpiled products must be stored in the UK. In the event of a shortage in the UK, the authority can direct the supplier to buy back all or some of the stock they hold, and release it through the normal UK supply chain. In the period leading up to expiry of the agreement, the supplier will be required, through an agreed exit plan, to buy back the stock. The agreement is for twelve (12) months with the authority having the option (at its sole discretion) to extend the contract for up to two (2) periods of six (6) months.
Direct Award against NHS Supply Chain Framework — Renal Replacement Therapies Services, Technologies and Consumables — Lot .3


Winner: B. Braun Medical Ltd
Award value: 500703.4
Number of bids: 3